The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.k

Sarcoid-like granulomatosis (endo-/extrathoracic)

Publications

Yukawa T, Shimizu K, Hirami Y, Maeda A, Yasuda K, Nakata M

Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.

Asian cardiovascular & thoracic annals. 2013;21(6):732-4

Inoue K, Goto R, Shimomura H, Fukuda H

FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment.

SpringerPlus. 2013;2(1):113

Kornacker M, Kraemer A, Leo E, Ho AD

Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.

Annals of hematology. 2002;81(2):103-5